The Trump administration’s most recent executive order tackles drug pricing in the United States and replaces an order that was supposed to be implemented on August 24, 2020. In this podcast episode, Eric Levin, CEO of Scripta Insights, discusses with Drug Topics® how “positive disruption” from private companies and innovators are better positioned to confront challenges within the pharmaceutical industry.